Cargando…
Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study
During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typic...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093645/ https://www.ncbi.nlm.nih.gov/pubmed/30110339 http://dx.doi.org/10.1371/journal.pone.0201282 |
_version_ | 1783347703477960704 |
---|---|
author | Nix, Eli B. Choi, Joshua Anthes, Christina Gaultier, Gabrielle N. Thorgrimson, Joelle Cox, Andrew D. Tsang, Raymond S. W. McCready, William G. Boreham, Douglas Ulanova, Marina |
author_facet | Nix, Eli B. Choi, Joshua Anthes, Christina Gaultier, Gabrielle N. Thorgrimson, Joelle Cox, Andrew D. Tsang, Raymond S. W. McCready, William G. Boreham, Douglas Ulanova, Marina |
author_sort | Nix, Eli B. |
collection | PubMed |
description | During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typically develop invasive Hia disease. To clarify factors responsible for an increased burden of invasive Hia disease in certain population groups we studied serum bactericidal activity (SBA) against Hia and quantified IgG and IgM specific to Hia capsular polysaccharide in healthy adult members of two First Nations communities: 1) with reported cases of invasive Hia disease (Northern Ontario, NO), and 2) without reported cases (Southern Ontario, SO), in comparison to non-First Nations living in proximity to the NO First Nations community, and non-First Nations elderly non-frail Canadians from across the country (total of 110 First Nations and 76 non-First Nations). To elucidate the specificity of bactericidal antibodies, sera were absorbed with various Hia antigens. Naturally acquired SBA against Hia was detected at higher rates in First Nations (NO, 80%; SO, 96%) than non-First Nations elderly Canadians (64%); the SBA titres in First Nations were higher than in non-First Nations elderly Canadians (P<0.001) and NO non-First Nations adults (P>0.05). Among First Nations, SBA was mediated predominantly by IgM, and by both antibodies specific to Hia capsular polysaccharide and lipooligosaccharide. Conclusions: The SBA against Hia is frequently present in sera of First Nations adults regardless of the burden of Hia disease observed in their community; it may represent part of the natural antibody repertoire, which is potentially formed in this population under the influence of certain epigenetic factors. Although the nature of these antibodies deserves further studies to understand their origin, the data suggest that they may represent important protective mechanism against invasive Hia disease. |
format | Online Article Text |
id | pubmed-6093645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-60936452018-08-30 Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study Nix, Eli B. Choi, Joshua Anthes, Christina Gaultier, Gabrielle N. Thorgrimson, Joelle Cox, Andrew D. Tsang, Raymond S. W. McCready, William G. Boreham, Douglas Ulanova, Marina PLoS One Research Article During the last two decades, Haemophilus influenzae serotype a (Hia) emerged as an important cause of invasive disease in Canadian First Nations and Inuit, and Alaskan Native populations, with the highest rates reported in young children. Immunocompetent adults, in contrast to children, do not typically develop invasive Hia disease. To clarify factors responsible for an increased burden of invasive Hia disease in certain population groups we studied serum bactericidal activity (SBA) against Hia and quantified IgG and IgM specific to Hia capsular polysaccharide in healthy adult members of two First Nations communities: 1) with reported cases of invasive Hia disease (Northern Ontario, NO), and 2) without reported cases (Southern Ontario, SO), in comparison to non-First Nations living in proximity to the NO First Nations community, and non-First Nations elderly non-frail Canadians from across the country (total of 110 First Nations and 76 non-First Nations). To elucidate the specificity of bactericidal antibodies, sera were absorbed with various Hia antigens. Naturally acquired SBA against Hia was detected at higher rates in First Nations (NO, 80%; SO, 96%) than non-First Nations elderly Canadians (64%); the SBA titres in First Nations were higher than in non-First Nations elderly Canadians (P<0.001) and NO non-First Nations adults (P>0.05). Among First Nations, SBA was mediated predominantly by IgM, and by both antibodies specific to Hia capsular polysaccharide and lipooligosaccharide. Conclusions: The SBA against Hia is frequently present in sera of First Nations adults regardless of the burden of Hia disease observed in their community; it may represent part of the natural antibody repertoire, which is potentially formed in this population under the influence of certain epigenetic factors. Although the nature of these antibodies deserves further studies to understand their origin, the data suggest that they may represent important protective mechanism against invasive Hia disease. Public Library of Science 2018-08-15 /pmc/articles/PMC6093645/ /pubmed/30110339 http://dx.doi.org/10.1371/journal.pone.0201282 Text en © 2018 Nix et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Nix, Eli B. Choi, Joshua Anthes, Christina Gaultier, Gabrielle N. Thorgrimson, Joelle Cox, Andrew D. Tsang, Raymond S. W. McCready, William G. Boreham, Douglas Ulanova, Marina Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study |
title | Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study |
title_full | Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study |
title_fullStr | Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study |
title_full_unstemmed | Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study |
title_short | Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study |
title_sort | characterization of natural bactericidal antibody against haemophilus influenzae type a in canadian first nations: a canadian immunization research network (cirn) clinical trials network (ctn) study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093645/ https://www.ncbi.nlm.nih.gov/pubmed/30110339 http://dx.doi.org/10.1371/journal.pone.0201282 |
work_keys_str_mv | AT nixelib characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT choijoshua characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT antheschristina characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT gaultiergabriellen characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT thorgrimsonjoelle characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT coxandrewd characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT tsangraymondsw characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT mccreadywilliamg characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT borehamdouglas characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy AT ulanovamarina characterizationofnaturalbactericidalantibodyagainsthaemophilusinfluenzaetypeaincanadianfirstnationsacanadianimmunizationresearchnetworkcirnclinicaltrialsnetworkctnstudy |